Abstract
Inborn errors of metabolism (IEM) include a broad spectrum of defects of various gene products that affect intermediary metabolism in the body. Studying the molecular and biochemical mechanisms of those inherited disorder, systematically summarizing the disease phenotype and natural history, providing diagnostic rationale and methodology and treatment strategy comprise the context of human biochemical genetics. This session focused on: (1) manifestations of representative metabolic disorders; (2) the emergent technology and application of newborn screening of metabolic disorders using tandem mass spectrometry; (3) principles of managing IEM; (4) the concept of carrier testing aiming prevention. Early detection of patients with IEM allows early intervention and more options for treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Chace, D.H., Kalas, T.A., 2005. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin. Biochem., 38(4):296–309. [doi: 10.1016/j.clinbiochem.2005.01.017]
Guthrie, R., 1969. Screening for phenylketonuria. Triangle, 9:104–109.
Hoffmann, G., Sweetman, L., 1987. O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatives for quantitative gas chromatographic and gas chromatographic-mass spectrometric studies of aldehydes, ketones and oxoacids. J. Chromatogr., 421:336–343.
Author information
Authors and Affiliations
Additional information
Special topic report in the First Hangzhou International Symposium on the Medical and Laboratory Applications of Medical Genetics and Genomics held in Hangzhou, China, 2005
Rights and permissions
About this article
Cite this article
Yu, C., Scott, C.R. Human biochemical genetics: An insight into inborn errors of metabolism. J. Zhejiang Univ. - Sci. B 7, 165–166 (2006). https://doi.org/10.1631/jzus.2006.B0165
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1631/jzus.2006.B0165